Clinical Lentivirus/AAV Manufacturing Facility
Challenge from the Client
Our client required an "out of the box," fast-track execution strategy to bring their clinical gene therapy manufacturing facility from business case to installation and operational qualification in 12 months.
Our Approach & Solution
IPS proposed their iCON delivery strategy, an offsite fabricated modular solution composed of a series of cleanroom "boxes" or PODs, engineered around the clients manufacturing process. The iCON team took their pre-engineered ÜBERcellFLEX24 modules and optionalized them to meet the gene therapy process requirements, effectively shaving several months off the design and fabrication schedule. The ÜBERcellFLEX units were constructed and FAT'd in a factory in Ireland before being shipped to the construction site in Europe.
The Results
Our client was able to fast-track their project in an adjacent factory model to their normal business operations. They were able to procure a single source EPCMV solution for the entire project that included both onsite and offsite design, procurement, construction and qualification.
Related Molecules
Gene Therapy Facility
Read MoreOur client needed an efficient design for their gene biologics plant within an existing building with limited space for air handlers and mechanical equipment.
Commercial Manufacturing of Autologous Muscle Derived Cell (AMDC) products
Read MoreApplying industry-leading knowledge and expertise to support CGMP-compliant manufacturing process scale-up.
Clinical CAR-T Capabilities
Read MoreA global biopharmaceutical manufacturer chose iCON to expedite its CAR-T therapy production timeline.
Site Selection for an Advanced Gene Therapy Company
Read MoreOur client was looking for a new site for their 2000L scale gene therapy manufacturing facility in a very saturated real estate market.
Mammalian Cell Culture to COVID-19 Vaccine Adjuvant in 3 weeks
Read MoreSoon after the COVID-19 outbreak, our client's direction shifted quickly from a mammalian cell culture facility to a COVID-19 vaccine adjuvant production facility.
Delivering a New Building with Two Project Teams
Read MoreProvided a client and building tenant with construction management services for the interior fit-out of a new 50,000sf pharmaceutical testing facility while a separate vendor constructs the core & shell for the landlord.
